A detailed history of National Asset Management, Inc. transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, National Asset Management, Inc. holds 8,867 shares of CRSP stock, worth $460,019. This represents 0.01% of its overall portfolio holdings.

Number of Shares
8,867
Previous 16,810 47.25%
Holding current value
$460,019
Previous $1.15 Million 58.25%
% of portfolio
0.01%
Previous 0.03%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 19, 2024

SELL
$51.17 - $68.18 $406,443 - $541,553
-7,943 Reduced 47.25%
8,867 $478,000
Q1 2024

May 16, 2024

BUY
$60.67 - $89.12 $2,730 - $4,010
45 Added 0.27%
16,810 $1.15 Million
Q4 2023

Mar 15, 2024

SELL
$38.62 - $72.18 $1,737 - $3,248
-45 Reduced 0.27%
16,765 $1.05 Million
Q3 2023

Dec 01, 2023

BUY
$45.39 - $59.0 $390,217 - $507,223
8,597 Added 104.68%
16,810 $763,000
Q2 2023

Jul 27, 2023

BUY
$43.47 - $67.77 $78,289 - $122,053
1,801 Added 28.09%
8,213 $461,000
Q1 2023

May 17, 2023

SELL
$41.0 - $56.12 $9,307 - $12,739
-227 Reduced 3.42%
6,412 $290,000
Q4 2022

Mar 15, 2023

SELL
$39.19 - $65.67 $7,838 - $13,134
-200 Reduced 2.92%
6,639 $269,000
Q4 2022

Feb 21, 2023

SELL
$39.19 - $65.67 $47,576 - $79,723
-1,214 Reduced 15.08%
6,839 $278,000
Q3 2022

Nov 14, 2022

SELL
$61.1 - $83.78 $26,334 - $36,109
-431 Reduced 5.08%
8,053 $527,000
Q2 2022

Aug 12, 2022

BUY
$43.23 - $73.83 $49,930 - $85,273
1,155 Added 15.76%
8,484 $516,000
Q1 2022

May 02, 2022

BUY
$53.19 - $79.24 $14,627 - $21,791
275 Added 3.9%
7,329 $461,000
Q4 2021

Jan 28, 2022

SELL
$70.09 - $111.29 $195,901 - $311,055
-2,795 Reduced 28.38%
7,054 $535,000
Q3 2021

Nov 16, 2021

BUY
$110.2 - $156.64 $378,316 - $537,745
3,433 Added 53.51%
9,849 $1.1 Million
Q2 2021

Aug 10, 2021

BUY
$100.84 - $161.89 $146,823 - $235,711
1,456 Added 29.35%
6,416 $1.04 Million
Q1 2021

May 13, 2021

BUY
$110.72 - $210.04 $84,257 - $159,840
761 Added 18.12%
4,960 $605,000
Q4 2020

Feb 04, 2021

SELL
$79.67 - $173.23 $25,255 - $54,913
-317 Reduced 7.02%
4,199 $643,000
Q3 2020

Nov 09, 2020

BUY
$78.5 - $100.64 $10,126 - $12,982
129 Added 2.94%
4,516 $378,000
Q2 2020

Jul 31, 2020

SELL
$38.5 - $76.05 $12,936 - $25,552
-336 Reduced 7.11%
4,387 $323,000
Q1 2020

May 06, 2020

BUY
$33.68 - $62.53 $639 - $1,188
19 Added 0.4%
4,723 $201,000
Q4 2019

Feb 10, 2020

BUY
$36.68 - $73.13 $172,542 - $344,003
4,704 New
4,704 $287,000
Q3 2019

Nov 12, 2019

SELL
$40.99 - $52.56 $314,762 - $403,608
-7,679 Closed
0 $0
Q2 2019

Aug 05, 2019

BUY
$35.45 - $48.2 $272,220 - $370,127
7,679 New
7,679 $362,000

Others Institutions Holding CRSP

About CRISPR Therapeutics AG


  • Ticker CRSP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,009,296
  • Market Cap $4.05B
  • Description
  • CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....
More about CRSP
Track This Portfolio

Track National Asset Management, Inc. Portfolio

Follow National Asset Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of National Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on National Asset Management, Inc. with notifications on news.